GENE ONLINE|News &
Opinion
Blog

Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases

by GeneOnline
Share To
Gene therapies have dramatically altered the landscape of neurological disease treatments, with the USFDA expecting to review 10 to 20 cell and gene therapies each year by 2025. Over 1000 gene therapy studies are currently underway for neurological diseases. Here, we attempted to review the field. Although the genetic basis underlying common neurological and neuromuscular disorders

GO Prime with only $1.49 now

LATEST
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
EVENT
Scroll to Top